SC
Savant Capital Portfolio holdings
AUM
$18.9B
1-Year Est. Return
14.6%
1 Year Est. Return
+14.6%
AUM
$18.9B
AUM Growth
+$2.78B
(+17%)
Holding
2,041
Top Buys
| 1 | +$197M | |
| 2 | +$126M | |
| 3 | +$86.2M | |
| 4 |
Dimensional US Large Cap Value ETF
DFLV
|
+$85M |
| 5 |
Avantis International Large Cap Value ETF
AVIV
|
+$65.7M |
Top Sells
| 1 | +$22.5M | |
| 2 | +$21.9M | |
| 3 | +$16.2M | |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$8.15M |
| 5 |
Dimensional International Small Cap ETF
DFIS
|
+$7.76M |
Sector Composition
| 1 | Technology | 5.87% |
| 2 | Financials | 3.05% |
| 3 | Industrials | 2.85% |
| 4 | Healthcare | 2.34% |
| 5 | Consumer Discretionary | 2.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Strategic Education
STRA
$1.86B
| – | – |
-2,893
|
|
||
|
SWTX
2027
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-11,278
|
|
||
2028
Willis Lease Finance
WLFC
$817M
| – | – |
-1,431
|
|
||
2029
Wabash National
WNC
$350M
| – | – |
-12,920
|
|
||
2030
Expro
XPRO
$1.59B
| – | – |
-12,053
|
|
||
2031
FibroBiologics
FBLG
$15.8M
| – | – |
-10,940
|
|
||
2032
Corpay
CPAY
$20.7B
| – | – |
-1,380
|
|
||
2033
Molson Coors Class B
TAP
$9.18B
| – | – |
-4,969
|
|
||
2034
Teck Resources
TECK
$21B
| – | – |
-5,343
|
|
||
2035
Tenaya Therapeutics
TNYA
$201M
| – | – |
-85,283
|
|
||
2036
Tronox
TROX
$610M
| – | – |
-57,304
|
|
||
2037
Trupanion
TRUP
$1.47B
| – | – |
-3,708
|
|
||
2038
Tradeweb Markets
TW
$22.9B
| – | – |
-4,834
|
|
||
2039
Unisys
UIS
$189M
| – | – |
-14,496
|
|
||
2040
Unifirst Corp
UNF
$3.18B
| – | – |
-1,224
|
|